Researchers are comparing the new-look Topaz TTVR system from TRiCares with the FDA-approved Evoque TTVR system from Edwards Lifesciences. 

Eplontersen, a once-monthly ATTR-CM medication from AstraZeneca and Ionis Pharmaceuticals, failed to meet the primary endpoint of a new placebo-controlled analysis. The companies are still reviewing the final data, which will be presented to the public in August. 

Lisa Nee, MD, a former interventional cardiologist and public policy advisor, has officially joined a crowded mayoral race. 

The new Dual-Energy ThermoCool SmartTouch SF Platform delivers RF and PF energy through a single catheter. 

The long-lasting implant could help patients benefit from semaglutide therapy without needing to take the drug on a daily basis. 

Immediate aspirin discontinuation after PCI is associated with an increased risk of ischemic events, according to a new analysis of nearly 8,000 patients.

Cardiology remains the No. 2 healthcare specialty for AI approvals, trailing only radiology. 

Major TAVR policy changes appear to be on the way—should clinicians be excited or concerned? Leading U.S. medical societies are sharing their early reactions.

Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness. 

The complaint says the patient was left in agony, forcing her to show up at the emergency room nine days later. Both the hospital and the podiatrist are named as defendants.

Disclosing the utilization of AI is not enough to ensure the integrity of manuscripts, the editor-in-chief of a prominent radiology journal cautions.